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Chronic Obstructive Pulmonary Disease (COPD), a respiratory disease that leads to 
reduced airflow, may result in difficulty swallowing with disease progression. The 
coordination between the respiratory and swallowing systems decouple and they 
may experience increased risk of aspiration. This study aimed to determine the 
effects of lung volume on swallowing in individuals with COPD compared with older 
healthy. Specifically, the study examined if altering lung volume at the time of the 
swallow changed swallowing timing, specifically pharyngeal swallow duration, and 
impacted the respiratory-swallow pattern in individuals with COPD.  Measurement 
of estimated lung volume (ELV), pharyngeal swallow duration, and respiratory-
swallow patterning in individuals with COPD was compared with older healthy at 
varying lung volume conditions. Participants completed seven 20 ml water bolus 
swallows by medicinal cup across 4 lung volumes: non-cued volume (NC), and in 
order of increasing volume, resting expiratory level (REL), tidal volume (TV), and 
total lung capacity (TLC) . ELV was determined using respiratory inductive 
plethysmography (RIP) and spirometry.  Swallow timing was measured by events 
during the swallow with pharyngeal manometry.  Individuals with COPD had lower 
lung volumes at the time of the swallow than older healthy individuals. A moderate 
to strong negative relationship between estimated lung volume at the time of the 
swallow and pharyngeal swallow duration was found in individuals with COPD that 
was not present in the healthy participants. They had a longer pharyngeal duration 





inspiration post-swallow were significantly greater in individuals with COPD than 
the healthy. In the COPD group, resumption of respiration in inspiration occurred 
significantly less often at the higher lung volumes (TLC and TV) than the lower 
volume condition, REL.  In conclusion lower lung volumes at the time of the swallow 
in individuals with COPD were associated with longer pharyngeal swallow duration 







The American Thoracic Society (ATS), European Respiratory Society (ERS) 
and Global Initiative for Chronic Obstructive Lung Disease (GOLD) define Chronic 
Obstructive Pulmonary Disease (COPD) as a respiratory disease characterized by 
reduced airflow that is not reversible by use of a bronchodilator or anti-
inflammatory therapies (Celli et al, 2004). COPD is preventable and treatable. The 
World Health Organization predicts that COPD will be the third most prevalent 
disease and rank fifth in level of disability by 2020 (O’Kane & Groher, 2009).  The 
National Heart, Lung, and Blood Institute estimated an annual cost of managing 
COPD at $50 billion. COPD is the fourth leading cause of mortality in the United 
States and Europe (Celli et al., 2004). Dysphagia, impairment in swallowing, is 
present in 27% of individuals with COPD and the incidence of dysphagia increases 
with COPD disease progression (McKinstry, Tranter, & Sweeney, 2010). Patients 
with COPD demonstrate a discoordination between breathing and swallowing that 
may be related to increased respiratory drive. Respiratory and swallowing 
discoordination places patients at risk for penetration or aspiration, entrance of 
food or liquid into the airway, and aspiration pneumonia (Coelho, 1987; Cvejic et al., 
2011).  Further, adverse events such as increased hospitalizations and higher 
mortality rates occur in individuals with COPD and dysphagia (Cvejic et al., 2011). 
Historically, individuals with COPD were labeled with a range of obstructive 





efforts were instrumental in ensuring consistent, centralized diagnosis with the 
umbrella term, COPD, to improve healthcare service delivery.  Noxious particle or 
gas exposure such as cigarette smoke, chemicals, or other toxins results in chronic, 
abnormal inflammation of the lungs.  In addition to inflammation reducing airflow, 
emphysema impairs the elastic integrity of the alveolar sacs within the lungs 
resulting in hyperinflation or air trapping (Celli et al., 2004; Hess, MacIntyre, 
Mishoe, Galvin & Adams, 2012). Chronic bronchitis is indicated when an individual 
has a productive cough lasting for three months or longer in two consecutive years 
which cannot be explained by another condition (Celli et al., 2004). However, Hess 
et al. (2012) cautions that individuals diagnosed with chronic bronchitis do not all 
meet the irreversible airflow obstruction criteria for the COPD diagnosis. In the past, 
individuals with repetitive airway inflammation presentation were labeled with 
chronic bronchitis; however, in recent years, practitioners have been urged to 
diagnose individuals with ‘airway disease’ (Hess et al, 2012). The preferred term, 
airway disease, addresses the pulmonary changes evidenced in the central and 
peripheral airway as opposed to the pulmonary changes only in the central airway 
suggested by the chronic bronchitis definition (Hess et al., 2012). While cystic 
fibrosis, bronchiolitis obliterans and bronchiectasis cause chronic limited airflow, 
these conditions are not classified within COPD (Hess et al., 2012). Additionally, 
individuals with asthma are rarely diagnosed with COPD (Mannino, 2002).  
The gold standard for diagnosing COPD is spirometry, a “standardized and 
reproducible test that objectively confirms the presence of airflow obstruction” 





functioning testing (PFT). With calibration, spirometry is used to measure the 
volume of air and rate of air movement (airflow) during an individual’s inhalation 
and exhalation. The airflow and volume measurements are obtained by having the 
individual breathe into a mouthpiece while in the sitting or standing position (Hess 
et al., 2012). FEV1 is the amount of air an individual can forcefully exhale in one 
second. Forced vital capacity (FVC) is the total air volume an individual exhales with 
force after a large inspiration. Diagnostic testing with spirometry can measure 
forced expiratory volume in one second (FEV1) divided by forced vital capacity 
(FVC)1. A ratio of 0.7 documents the required airflow limitation to meet the COPD 
diagnosis criteria (Celli et al., 2004).   
COPD severity, determined via a classification scale such as the GOLD staging 
system shown in Table 1, is based on the measured amount of lung function 
impairment using spirometry (Mannino, 2002). The GOLD staging system is a 5-
stage scale (0-IV) ranging from ‘at risk’ (0) to ‘very severe’ (IV). In addition to the 
use of the fixed FEV1/FVC ratio 0.7 confirming COPD diagnosis, the percent forced 
expiratory volume in 1 second (FEV1%) is utilized to stage individuals with COPD 
(Celli et al., 2004; Hess et al., 2012). The FEV1% is derived by comparing an 
individual’s expiratory volume in one second to his/her peers of a similar age, 
gender, height and mass.  Celli et al. (2004) recognized limitations in singular use of 
spirometry outcomes for severity staging and suggested stronger consideration of 
body mass index (BMI) and dyspnea evaluation during exercise. However, the GOLD 
                                                     
1 FEV1/FVC is the amount of air that can be forcibly exhaled in one second divided the amount of air that 





severity staging scale, based on spirometry results, continues to be the most widely 
accepted rating scale. 
Table 1 
GOLD COPD Severity Staging 
Stage Description Findings: Postbronchodilator 
0 At risk FEV1/FVC  0.7  
I Mild FEV1/FVC < 0.7; FEV180% 
II Moderate FEV1/FVC < 0.7 
FEV1 at 50 to 80% 
 
III Severe FEV1/FVC < 0.7 
FEV1 at 30% to 50% 
 
IV Very Severe FEV1/FVC < 0.7 
FEV1 at 30% or FEV150% 
with severe chronic symptoms 
Note. FEV1 ratios are based on a percentage of predicted normal value given age, gender, 
height, mass and ethnicity. 
 
Symptoms associated with COPD are dyspnea (shortness of breath) on 
exertion, chronic cough, sputum expectoration and wheezing. Pursed-lip breathing 
with prolonged expiration, barrel chest, accessory muscles usage during respiration 
and cyanosis may also be present in individuals with COPD (Juvelekian & Stoller, 
2010). Non-pulmonary complications may include: cardiovascular disease, 
peripheral edema, cachexia (wasting syndrome), skeletal muscle dysfunction, 
osteoporosis, and depression (Hess et al., 2012).  Celli et al. (2004) identified COPD 
risk factors to include:  
 Smoking 






 Environmental pollution 
 Perinatal events and childhood illness 
 Recurrent bronchopulmonary infections 
 Diet 
 Genetic predisposition 
 Gender 
 Airway hyperactivity and asthma  
  Exacerbation of COPD is defined as acute changes in: (1) dyspnea level, (2) 
cough, and/or (3) sputum which require adjustments in regularly prescribed 
medications (Celli, 2004).  COPD exacerbations result in inflammation which may 
cause irreversible disease severity progression (Hess et al., 2012).  Medical 
management for exacerbations may include: (1) a course of corticosteroids, (2) 
antibiotic therapy, (3) oxygenation therapy adjustments to maintain  90% SpO2 
while minimizing CO2 retention, and (4) intubation with ventilation (Hess et al., 
2012). Individuals with an exacerbation of COPD have demonstrated a statistically 
significant higher respiration rate (24 breaths/minute) in comparison with healthy 
elderly individuals (15.6 breaths/minute) (Shaker et al., 1992).  
The cause of COPD exacerbations is still a point of debate in the medical 
community although increased aspiration and penetration have been posited as a 
trigger for an exacerbation onset (Gross et al., 2009; Terada et al., 2010). Abnormal 
swallowing in COPD is associated with a significantly increased frequency of COPD 
exacerbations per year than in individuals without swallowing impairment after 





decline during a COPD exacerbation, such as increased dyspnea and tachypnea, 
further impair the respiratory-swallow coordination and result in greater 
penetration and/or aspiration.   This evidence suggests a relationship between 
altered swallowing and increased frequency of COPD exacerbations. 
Airway protection during a swallow requires a cessation of respiration, or 
“swallow apnea”, ranging from .75-1.5 seconds while the bolus passes through the 
pharynx followed by a resumption of respiration signaling the end of the swallow 
(Klahn & Perlman, 1999; Martin-Harris, 2008; Perlman, He, Barkmeier & Leer, 
2005).  This suggests a central coordination between the respiratory and 
swallowing central pattern generators (Broussard & Altschuler, 2000; Jean, 1984).  
Young healthy individuals typically couple a swallow with the expiratory phase of 
respiration (Cedborg et al., 2010; Martin-Harris et al., 2005; Martin-Harris, Brodsky, 
Price, Michel, & Walters, 2003; Shaker et al., 1992; Wheeler Hegland, Huber, Pitts, 
Sapienza, 2009).  Specifically, they initiate the swallow and resume respiration after 
the swallow during the expiratory phase (E-E pattern) of the respiratory cycle 
(Martin-Harris et al., 2005). Resumption of respiration in the expiratory phase after 
the swallow is posited to reduce aspiration risk. Deviations in the respiratory-
swallow patterning occur in older healthy individuals resulting in more frequent 
onset of the swallow during inhalation (I-E or I-I pattern) or respiratory resumption 
in the inspiration cycle after the swallow (E-I or I-I pattern) than in younger healthy 
persons (Shaker et al., 1992). Individuals with moderate to severe stable state COPD 
have an altered respiratory-swallow patterning; specifically, they swallow solids in 





(Gross, Atwood Jr., Ross, Olszewski, & Eichhorn, 2009). COPD patients in the 
exacerbated state resume respiration post-deglutitively in the inspiratory phase 
more frequently than healthy older peers (Shaker et al., 1992).  
  In addition to the reduction in respiratory-swallow pattern coordination, 
individuals with COPD demonstrate: (1) diminished laryngeal elevation during the 
swallow, (2) trending towards a lower laryngeal position at rest, (3) increased 
pharyngeal transit duration, (4) fatigue of oral mastication with need for rest 
breaks, (5) lingual peristalsis, (6) cricopharyngeal dysfunction and (7) a voluntary 
prolongation of airway closure on certain bolus types (Coelho, 1987; Mokhlesi, 
Logemann, Rademaker, Stangl, & Corbridge, 2002; Chaves et al., 2014).  Pharyngeal 
residue in individuals with stable COPD is not significantly different from their 
healthy older peers (Chaves et al., 2014). Severe COPD individuals also demonstrate 
severe cricopharyngeal dysfunction and particular difficulty with opening of the 
upper esophageal segment for bolus passage into the esophagus. Some have 
suggested that there is a correlation between cricopharyneal dysfunction and 
gastroesophageal reflux (GER) (Stein, Williams, Grossman, Weinberg & 
Zuckerbraun, 1990). Persons with severe COPD have a higher prevalence of GER 
than healthy individuals. Further, GER was identified as a risk factor for 
exacerbations (Sakae, Pizzichini, Teixeira, da Silva, Trevisol & Pizzichini, 2013).  
Mechanisms driving respiratory-swallow coordination are largely unknown. 
Central pattern coordination between respiration and swallowing involves neurons 





1984).  Sensory feedback to the respiratory and swallowing central systems prior to 
swallowing is important for airway protection during swallowing (Table 2).  
Increases in lung volume will activate pulmonary stretch receptors and increase 
recoil forces in the chest wall (Gross, Steinhauer, Zajac, & Weissler, 2006; Gross et 
al., 2012). Pulmonary stretch receptors provide peripheral feedback to the medulla 
on lung volumes achieved before swallowing. Inadequate volumes are reported to 
alter the coupling of respiration and swallowing and result in timing variances that 
reduce airway safety (Gross et al., 2003). 
Table 2 
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Given the bronchoconstriction and hyperinflation in COPD, lung volume is 
posited as impaired in swallowing (Table 3). Decreased airflow within the smaller 
airways, along with thoracic muscle wasting with disease progression and 
hyperinflation, reduce lung volume in individuals with COPD (Gatta, Fredi, 
Aliprandi, Pini, & Tantucci, 2013). Vital capacity measures of total lung volume were 
reduced to 2.72 L (SD=.72) in COPD from the normal expected range of 3-5 L (Yuan 





pulmonary stretch receptor input and reduce thoracic recoil.  Further, a decrease in 
expiratory airflow results in hyperinflation. An examination of the role of lung 
volume on swallowing control in persons with COPD is needed. 
Table 3 
Proposed Mechanisms Affecting Swallowing Coordination in COPD 
Respiratory Abnormality in COPD Mechanisms affecting Swallowing in COPD 
Reduced Vital Capacity 
 
Airway obstruction on Inspiration and 
Expiration   
Thoracic Muscle Wasting,  
Decreased Recoil 
Reduced Expiration Speed Airflow obstruction 
Decreased Mechanical Recoil during 
Passive Expiration 
Reduced Inspiration Volume Hyperinflation 










This research project investigated the role of lung volume in the coordinated 
coupling of breathing and swallowing in individuals with COPD when compared 
with healthy individuals.  The study examined how individuals with COPD swallow 
at different lung volumes compared to older healthy individuals. In particular, the 
effects of swallowing at different lung volumes on timing measures during 
swallowing were investigated. Respiratory-swallow patterning in COPD is known to 
vary from healthy individuals with more frequent resumption of respiration in the 
inspiratory phase thus increasing the risk of aspiration. This study examined 
whether swallowing at a higher lung volume changed timing of the pharyngeal 









Problem: Mechanism for dysphagia in COPD is not known. 
 
Aim: Examination of the Relationship between Lung Volume and Swallowing 
Control in COPD 
The study contrasted varying lung volume during swallowing between individuals 
with COPD and healthy participants. Further, the effects of lung volume 
manipulation on temporal measures of swallowing such as pharyngeal duration 
were determined. Respiratory-swallow patterning in COPD participants was also 
compared across lung volume conditions. 
Hypotheses:  
1. Lung volumes for swallowing would be significantly lower in COPD than in 
healthy participants.  
 
2. Pharyngeal swallow duration will be related to lung volume at the time of the 
swallow in COPD participants. Specifically, pharyngeal duration will decrease 
when increasing lung volume in individuals with COPD.  
 
3. Swallowing at higher lung volumes would result in less frequent resumption 
of respiration during inspiration than lower lung volume conditions in 
individuals with COPD.   
 
Collectively, this research examined the effects of lung volume on swallowing in 
individuals with COPD. It was determined whether lung volume abnormalities 
related to difficulties in the coordination of breathing and swallowing in COPD. Also, 
the effects of lung volume changes were examined on pharyngeal swallowing timing 








Individuals with COPD are at increased risk for swallowing impairment 
resulting in aspiration and aspiration pneumonia (Terada, 2010).  COPD patients 
demonstrating an impaired swallowing reflex also have increased COPD 
exacerbations (Terada, 2010).  A respiratory decline is evidenced in COPD 
exacerbations and patients frequently require hospitalization. Researchers 
hypothesize that aspiration may be a risk factor for COPD exacerbations in addition 
to risk of aspiration pneumonia. The lack of identification of the mechanisms driving 
the COPD patient’s swallowing impairment is a critical barrier to determining 
models to improve clinical outcomes in COPD.  Further, investigation of the effects of 
changes in lung volume is pivotal for developing appropriate treatment approaches.  
This study will identify the mechanism driving the swallowing impairment and 
determine if adaptations in volume can positively influence coordination between 
the respiratory and swallowing systems. The study will have a broader impact by 
providing a theoretical framework for additional clinical investigation studies aimed 
at improving swallowing function in COPD and other respiratory compromised 










The effects of varying lung volume on swallowing in individuals with COPD 
have not been investigated. Individuals with COPD exhibit progressive limitations in 
airflow which are not completely reversible. We hypothesize that a limitation in 
lung volume interferes with swallowing physiology and respiratory-swallow 
coordination in COPD patients. Previous studies in healthy adults, found a reduction 
in the lung volume amount at the time of the swallow resulted in alternations in 
swallowing physiology such as delays in swallowing onset and increases in the 
pharyngeal swallow duration (Gross, 2003).  Our study will examine some of these 
relationships in patients with COPD to better understand the mechanisms 
underlying this disorder. Although others have documented swallowing deficits in 
the COPD population, this research is the first aimed at establishing the 
pathophysiology of swallowing in COPD.  Without understanding the mechanisms 
involved in swallowing difficulties in this disorder, treatment cannot be aimed at 
improving the deficits in COPD.  Increases in duration of the swallow could increase 
the risk for aspiration in this respiratory compromised population. Mechanisms that 
may improve the coupling of respiration and swallowing in COPD are not known.  
Based on the first attempt to increase understanding of the pathophysiology of 
swallowing in COPD to be provided by this investigation, investigations altering the 
respiratory system by respiratory strength training could be relevant. Future 
investigations could focus on altering respiration for prevention of aspiration by 








1. Aim: Examination of the Relationship Between Lung Volume and Swallowing 
Control in COPD 
 
We determined: (1) lung volumes during swallowing in individuals with COPD in 
comparison with healthy participants (2) the effects of manipulating lung volume at 
time of swallow on swallowing physiology and (3) the effects of varying lung volume 
on the respiratory-swallow patterning in COPD.   
1.1 Background 
Wheeler-Hegland et al. (2009) reported that healthy individuals (age range 
19-28) swallow at 43-64% of vital capacity. Participants were observed to inspire or 
expire to achieve the preferred lung volume (% VC) at the time of the swallow. The 
vital capacity volume in individuals with COPD is reduced to 2.72 L (SD=.72) from 
the normal expected range of 3-5 L (Yuan et al., 2014). The lung volume levels when 
COPD individuals swallow is not known but is posited to be lower than healthy older 
volunteers. Thus, individuals with COPD may need to swallow at a higher 
percentage of their vital capacity to swallow safely. 
  One study found a reduction in lung volume at the time of swallow resulted 
in delays in swallow onset and longer pharyngeal phase durations in healthy 
participants (Gross, 2003).  COPD patients had longer pharyngeal durations when 
compared with healthy volunteers completing bolus swallows at their typical lung 





closure for certain bolus types in 45% of COPD participants and suggested this was 
a potential compensation mechanism to protect the airway. 
A study examining the effects of swallowing at varying lung volumes in COPD 
may identify mechanisms to help these patients swallow safely.  
1.2   Purpose  
Determine the effects of varying lung volume on swallowing control in COPD. 
1.3 Hypotheses 
1. Lung volumes for swallowing will be significantly lower in COPD than 
in healthy participants.  
 
2. Swallow duration will demonstrate a negative relationship with lung 
volume in individuals with COPD. Specifically, individuals with COPD 
will decrease their pharyngeal duration when swallowing at increased 
lung volumes. 
 
3. Swallowing at higher lung volumes will result in less frequent 
resumption of respiration during inspiration than lower lung volume 
in individuals with COPD. 
 
1.4 Independent Variables  
 Participant group (Healthy or COPD) 
 Lung volume condition  ( Table 4) 
Table 4 
Lung Volume Condition Definitions  
Condition Abbreviation Operational Definition 
Non-Cued NC No instruction of when to swallow 
Resting Expiratory Level REL Bottom of tidal breath 
Tidal Volume TV Peak of tidal breath 





1.5 Dependent Variables (Table 5) 
Table 5 
Dependent Variable Definitions and Measurement 




Estimated volume at 
time of the swallow 
(Liters) 
*%VC will be reported 
 Respiratory inductive 
plethysmography (RIP) 





Onset of BOT pressure 
increase to upper 
esophageal sphincter 
(UES) negative pressure 
offset 
 Time of BOT onset pressure 
increase 
o BOT manometer pressure 
sensor 
 Time of  offset of negative UES 
pressure (at second peak in M 
wave) 






























We studied the relationship between respiratory functioning and swallowing 
functioning in persons with COPD when compared to healthy peers. 
Participants  
Healthy and COPD participants were 45 years of age or older to participate.  
Inclusion criteria for COPD participants were: (a) a respiratory function screening 
ratio result of 30% to < 70% (Ratio of forced expiratory volume in 1 second to 
forced vital capacity via spirometry) (Celli et al., 2004), (b) COPD diagnosed by a 
physician, (c) no exacerbation of COPD within last month, (d) no use of continuous 
oxygen (O2) and (e) not diagnosed with bullous emphysema. COPD group 
respiratory function screening ratio was M=51.67% (SD=8.31). The percent 
predicted FEV1, determining COPD severity, ranged 34% to 80%. Applying the GOLD 
COPD severity rating scale (Table 1), COPD participants’ severities were: one mild, 
three moderate, and five severe COPD.  One COPD participant was prescribed 
supplemental oxygen at a rate of 2L O2 by nasal cannula at night and as needed 
during exertional activities. This participant did not use oxygen during the study. 
Healthy participants demonstrated a respiratory function screening ratio of 70% 
FEV1/FVC for inclusion in the healthy group, M=82.2% (SD=7.4). Healthy 
participants scored 8 or less (normal) on the Dysphagia Handicap Index (DHI) 
which is a 100 point scale based on patient reports of swallowing difficulty 
(Silbergleit, Schultz, Jacobson, Beardsley & Johnson, 2012). COPD participants 





participation (see additional discussion of DHI in Other Screening Tools, p.31). 
Three COPD participants exceeded the normal range on the DHI, 2 mild and 1 
moderate.  The moderate scoring participant was previously evaluated by a speech-
language pathologist and diagnosed with dysphagia, but had not yet received 
treatment. Healthy and COPD prospective participants also met a minimum score of 
21 points on Mini Mental State Evaluation (MMSE) (21-24 points=mild, 25-30 
points=normal cognition) (Folstein, Folstein & McHugh, 1975) and had a Reflux 
Symptom Index (RSI) score <15.  Additional exclusion criteria for COPD or healthy 
participants were:   
 Direct dysphagia treatment within the last 3 months 
 History of brain injury or stroke 
 Diagnosed with progressive neurodegenerative disorders such as Parkinson’s 
Disease, multiple sclerosis, peripheral neuropathy, and amyotrophic lateral 
sclerosis  
 Previous neck injury requiring physician intervention  
 History of psychiatric disorder other than medically managed depression 
 Have a speech disorder with reduced ability to be understood by others 
 History of epileptic seizures 
 Inability to speak or understand English.  
Healthy participants were recruited through James Madison University (JMU) 
bulk emails and handouts or flyers at JMU.  COPD volunteers were recruited through 





clinics such as pulmonology, cardiopulmonary rehabilitation clinic, or other 
surrounding area healthcare providers within a one hour radius of the research site.  
Community flyers and word of mouth recruitment methods were also employed in 
recruitment of healthy and COPD volunteers. Telephone screens for inclusion 
eligibility were conducted for each prospective participant.  Informed consent and 
the experimental study were conducted at the Voice and Swallowing Services clinic 
in the Outpatient Treatment Center at Sentara RMH. Prospective participants 
completed screening tasks for inclusion on the date of their scheduled visit after 
completing informed consent. The study took 3 hours to complete including 
informed consent, screening, and the experimental tasks. A copy of the signed 
consent form was distributed to participants to take home. 
Instruments 
Instruments for measurement included: respiratory inductive 
plethysmography, oral pressure, 3-sensor manometry, and spirometry. The 
spirometer was utilized in the calibration tasks but was not used during the 
experimental swallow tasks.  Instruments used for identifying events included a 
single axis accelerometer, synchronized video recording and a button-push pulse 
generator.  
Estimated lung volume was measured with respiratory inductive 
plethysmography (RIP) (Respitrace®, Ambulatory Monitoring, Ardsley, NY) using 
two elastic inductobands around the rib cage (RC) and abdominal (AB) cavities 





The Respitrace® recorded chest wall and abdominal movement.  Although swallow 
apnea, the period of respiratory cessation (respiratory offset to respiratory 
resumption onset), has been reported in the literature as a method to determine 
pharyngeal phase timing (Martin, Logemann, Shaker, Dodd, 1994), respiratory onset 
or offset in the sum signal for RC and AB were not selected as temporal markers in 
this study because liquid swallows by cup have shown variable apnea onset signals 
(Martin-Harris, Brodsky, Price, Michel & Walters (2003). The RIP signal was used to 
determine inclusion or exclusion of a trial in a lung volume condition based on lung 
volume at time of swallow in real-time and off-line data analysis. Oral and 
pharyngeal pressure signals were used instead to mark durations in swallowing. 
Measurement of Respiratory Volume 
The RC inductoband was positioned at the axilla with the connector pins 
down and the AB band was placed below the last rib at the umbilicus with the 
connector pins up. The signals from the AB and RC respiratory bands were input 
into the oscillator module and RIP amplifier set on DC signal amplification with a 1:1 
amplification for RC and AB signals. The RC, AB and Sum signals were input into a 
16 channel PowerLab (ADInstruments, Dunedin, New Zealand).  A sampling rate of 
1K/s was applied in LabChart (ADInstruments, Dunedin, New Zealand) for signal 
analysis.   The bands were placed on the participant over tight fitting clothing for 
accurate measurement of ribcage and abdomen movement.  A mesh retainer was 
positioned on the participant after placement of the inductobands to reduce 





A Universal Ventilation Meter (UVM) spirometer (Vacu-Med®, Ventura, CA) 
was used during the calibration tasks. The bidirectional flow meter has a turbine 
transducer. The inhalation and exhalation signals are combined into a sine-wave 
signal by signal summation.  Signal input into the PowerLab included the 
inspiratory, expiratory and sum signals, each with a sampling rate of 1K/s. A new 
filter mouthpiece was attached to the spirometer head prior to use for each 
participant.  
Measurement of Pharyngeal Pressure 
A 3-sensor manometer, CTO-3(Gaeltec, Hackensack, NJ), was placed 
transnasally into the pharynx to measure pressure changes during the swallow. The 
flexible strain-gauge manometric probe was passed nasally and positioned in the 
upper airway with pressure sensors inferiorly to superiorly as follows: (1) top of the 
upper esophageal sphincter (UES) opening, (2) in the hypopharynx, and (3) at the 
base of the tongue. The changes in pressure were used to mark temporal events 
occurring in the sequence of the swallow.  This study obtained two event markers 
from the manometry signal: (1) the onset of increase in base of tongue pressure 
served as the onset of the pharyngeal phase of the swallow and (2) the offset of 
upper esophageal sphincter negative pressure signaled UES closure after the 








Placement of the Manometer 
The manometer was placed in a warm water bath before insertion to 
acclimate the catheter to body temperature versus room temperature.  Prior to 
manometer catheter insertion, participants were administered two puffs of Afrin 
into each nostril. The lubricated catheter was inserted into the predetermined left 
or right naris, passed over the soft palate and through the pharynx.  The Gaeltec 
CTO-3 diameter is 2.7 mm and 100 cm in length with numeric markings at 10 cm 
increments to guide placement. Participants were instructed to swallow water 





boluses to assist with manometer entry into the upper esophageal sphincter (UES) 
when directed by the speech-language pathologist.  Accurate positioning of the 
pressure transducer was determined by utilizing the pull-through placement 
method (Witte, Huckabee, Doeltgen, Gumbley & Robb, 2008). The catheter was 
swallowed into the upper esophagus with a typical reading of approximately 20 cm 
at the nares. The catheter was correctly positioned when a M-wave pattern was 
observed in the UES digitized data signal when asking the participant to swallow. 
The pressure transducer was repositioned by incrementally retracting 1 cm on the 
catheter until the peak-trough-peak signal was noted for the UES sensor signal and a 
single pressure peak was observed for the base of tongue and hypopharyngeal 
sensors in the LabChart signal. The manometry catheter was secured with Medipore 
tape at the nares and forehead after a stable signal was maintained. A strain-relief 
loop was adhered at the participant’s shoulder to prevent dislodging the catheter. 
The Gaeltec CTO- 3 pressure transducer was connected to a quad bridge amplifier 
(AD Instruments, Dunedin, New Zealand) with a Gaeltec connector, meeting 
ADInstruments specifications.  This connector allowed for 3 channel input to the 
bridge amp and LabChart.  A sampling rate of 10K for each channel was applied 
during digitization.  
A Glottal Enterprises (GE) PTL-1 oral pressure transducer and MS-110 data 
amplifier (Glottal Enterprises, Syracuse, NY) transduced intraoral air pressure 
changes during the swallow. The pressure transducer was connected to a 15 cm 
length Tygon® tubing (Model R-3603, Saint Gobain, Valley Forge, PA) with an 





mouth. The inner tubing diameter was 3 mm, outer diameter was 5 mm and the wall 
was 1 mm.  The new, oral tubing was individually fit to rest on the anterior tongue 
tip. The tubing was adhered to the cheek and the GE oral pressure transducer was 
strain-relieved to the face (see Figure 4). The oral pressure transducer was input to 
the GE MS-110® amplifier before entering the A-D converter, Power-Lab®. An 
event comment was entered into the oral pressure channel signal off-line based on 
the frame-by-frame synchronized video capture determination of bolus onset.  
For each participant, a single axis piezoelectric accelerometer (Kistler 
Instrument Co., Amherst, NY) taped with 3M transpore tape® to the skin and placed 
midline on the neck between the thyroid notch and the bottom of the  thyroid 
cartilage was used to detect laryngeal elevation onset.  The signal was input into the 
Kistler Piezotron power supply coupler (Type 5118B2, Kistler, Amherst, NY). A gain 
of 100 dB with a HP filter=.03 was applied at the power supply coupler.  Off-line 
data analysis was conducted using a 30 Hz high pass filter with signal rectification. 
Digital video capture (Logitech mountable with USB connection) of the oral and 
neck regions was temporally synchronized with the LabChart signal.  Video 
recording was at 30 frames/second.   
Calibration 
Respiratory Inductive Plethysmography Calibration into Liters 
Prior to the participant’s arrival, both the RC and AB signals were zeroed by  
pressing the Calibrate button and RC button to obtain a reading from the 





adjusted until a 0 was shown on the digital display. This process was repeated for 
the AB by leaving the Calibrate button pushed and depressing the AB button.  The 
sum button was depressed to ensure that the display still read zero and adjustments 
completed as needed with the AB zero knob. The Respitrace™ amplifier gain for 
both the RC and AB were set to 1.  Calibrate and reference buttons were pressed 
along with the RC. If the reading was other than 1, then the RC gain knob was 
adjusted until the digital display reads 1. This process was repeated with AB after 
pressing the AB button. Finally, the sum digital display read a gain of 2 to complete 
the Respitrace™ instrument calibration.  
Spirometer Calibration 
The UVM spirometer was calibrated by delivering a known volume across a 
known time to the spirometer head.  The spirometer turbine was placed on the GE 
calibrator unit (Glottal Enterprises, Syracuse, NY) using an adaptor and calibration 
filter. The flow setting on the GE calibrator was set for 1 L/sec and 2 L volume.  
Digitization in LabChart of the calibration flow cycle was initiated. Expiration and 
inspiration values (in volts) were highlighted and entered into the DataPad in 
LabChart for the second positive and zero segments. The 2 calibration points (in 
volts) for the known 1 L/s and 0 L/s flow for expiration and inhalation respectively 
were added to the DataPad and manually entered into LabChart as conversion units. 
Manometer Calibration-Oral Pressure 
Prior to the participant’s arrival, oral pressure offset was zeroed while 





reading from the oral pressure transducer (PTL-1, Glottal Enterprises, Syracuse, NY) 
in a room was set to 0 volts as the atmospheric pressure.  The GE calibrator unit was 
used to input a known pressure into the pressure transducer to complete a 2 point 
calibration process in LabChart.  The stopper was inserted in the top flow port (used 
for pressure calibration tasks) on the GE calibrator unit and the pressure transducer 
was inserted into the pressure port.  The setting on the GE calibrator was toggled to 
pressure. Digitizing in LabChart was initiated and the following pressures were 
applied: 0 mmHg, 3 mmHg, 5 mmHg, 7 mmHg, 10 mmHg, 15 mmHg. The pressure 
values (in volts) for the 5 mmHg and 15mmHg known pressure values were added 
to the DataPad and manually entered into the unit conversion.  The millimeters of 
mercury (mm Hg) measurement was used in this study.  
 












Figure 2.Manometer calibration. Catheter is inserted into pressure 







Manometer Calibration-Pharyngeal Pressure 
Prior to the participant’s arrival, the CTO-3 Gaeltec manometer calibration 
was a 2 part process. The manometer catheter was connected to the bridge 
amplifier. The three pressure sensors, base of tongue, hypopharyngeal and UES, 
were zeroed by selecting the zero function under the bridge amp tab in the channel 
menu. Each channel was zeroed separately. The digitizing display window 
demonstrated the pre-zeroed pressure reading graphically drop to zero. If zero, 
then the researcher pressed ‘okay’ to accept.  The second step was to determine 2 
calibration points for unit conversion from volts into mmHg pressure. Prior to 
beginning the calibration process, a battery tester was used to ensure adequate 
charge for the digital manometer calibrator.  The CTO-3 manometer was placed into 
a flexible tubing chamber attached to the Delta-Cal® digital pressure calibrator 
(Utah Medical, Midvale, UT) (Figure 2). The collet was tightened after the 3 sensors 
were placed deep in the chamber without risk of being damaged. Digitizing in 
LabChart was initiated while incremental known pressures were applied within the 
sealed tubing chamber connected to the Delta-Cal. The pressures applied included: 0 
mmHg (atmospheric pressure), 5 mmHg, 25 mmHg, 50 mmHg, 75 mmHg, 100 
mmHg, 125 mmHg, 0 mmHg, -25 mmHg, and -50 mmHg.  Based on the experimental 
tasks, signal recording values (in volts) were added to the DataPad for 50 mmHg 
and 125 mmHg from each of the 3 channels.  The conversion values from DataPad 





manometer sensors using conversion values of ranging -50 mmHg to 125 mmHg 





































Figure 3. Linear relationship during manometer calibration for base of 
tongue (BOT). A linear relationship was determined when applying a 
known pressure (mmHg) from the pressure calibrator to the BOT sensor in 
the manometer transducer. 
 
 
Figure 4. Linear relationship during manometer calibration for 
hypopharynx. A linear relationship was determined when applying a 
known pressure (mmHg) from the pressure calibrator to the hypopharynx 




















Determination of Rib Cage and Abdominal Ratios 
Before converting the RIP signal into volumes, the amplification ratios of the 
RC and AB contributions to lung volume was set for each individual in the seated 
position (Konno & Mead, 1967).  The RC and AB contributing factors were solved for 
in the following equation: estimated lung volume (ELV): spirometer= RC(x) + AB(y).  
The AB signal factor, “y”, was equal to 1 based on the study population and 
experimental tasks. Therefore, the equation was spirometer=RC(x) + AB(1) to 
compute the least errored solution for “x”.  The three tasks completed to determine 
 
Figure 5.  Linear relationship during manometer calibration for upper 
esophageal sphincter (UES). A linear relationship was determined when 
applying a known pressure (mmHg) from the pressure calibrator to the UES 







the calibration factor included tidal volume breathing, swallow-like breathing and 
vital capacity. Tidal volume breathing and swallow-like breathing trial files were 
exported off-line into a .RespCal MatLab program provided by Dr. Jessica Huber, 
Purdue University.  The MatLab script applied a pseudoinverse function to compute 
a least errored solution for “x”, the RC contribution ratio. 
Tasks 
Pulmonary Function Testing  
The pulmonary function test is the standard for confirming diagnosis of 
COPD and staging of severity based on the forced expiratory volume results (Celli, 
2004; Mannino, 2002). A bedside spirometer calculated the forced expiratory 
volume in 1 second (FEV1)/forced vital capacity (FVC) ratio. Participants took a 
deep breath while keeping a lip seal on a new, unused Moe filter (nSpire Health, Inc.; 
Longmont, CO) and blew out hard and fast until they had no additional air to expire. 
The screening task was completed with three trials in a seated position to match the 
experimental task positioning. The Koko Legend (nSpire Health, Inc.; Longmont, CO) 
bedside spirometer unit is regularly used in the clinical respiratory environment.  
The spirometer computed the FEV1/FVC ratio accounting for participant age, 
gender, height, and weight in determining expected values.  These values were 
entered using the touchscreen before beginning the screening task with the 
participant. The KoKo Legend provided printable graphic and table-type output. 
Healthy participants exceeded 70% and COPD participants performed at 70% or 





Calibration of the spirometer was completed prior to participant arrival 
using an nSpire 3 liter (L) canister. The calibration sequence prompts were 
provided on the touchscreen. The Koko Legend’s spirometer head zeros while held 
steady in the room without airflow.  The 3 L canister was securely fit to an nSpire 
Moe filter attached to the spirometer head. The canister plunger was pulled and 
plunged based on the time sensitive device prompts.  Graph and table calibration 
output was printed, reviewed, and included in the participant’s research file.  
Other Screening Tasks 
Participants completed the Dysphagia Handicap Index (DHI), a valid and 
reliable measure of the physical, emotional, and functional impact of swallowing 
difficulties on individuals (Silbergleit, Schultz, Jacobson, Beardsley, & Johnson, 
2012).  Responses to 25 statements were recorded as either always (4 points), 
sometimes (2 points) or never (0 points) resulting in a maximum potential score of 
100. The nine physical statements related to tangible symptoms such as coughing, 
weight loss or utilization of strategies to swallow better. Participant responses to 
nine functional statements focused on alterations in lifestyle such as alternative 
nutrition, taking longer to eat or altering their diet. The seven emotional statements 
addressed the participant’s perception of their response to difficulty swallowing 
such as being more fearful, experiencing avoidance, or being embarrassed.  DHI 
respondents also provided a self-perceived, overall severity of swallowing difficulty. 
Overall severity rating ranged 1 (normal) to 7 (severe problem) on an equal interval 





score of 8 on the 25 statements is within normal limits (Silbergleit et al., 2012). The 
cut-off score on the DHI for healthy participant inclusion was 8.  COPD participants 
completed the DHI but a requisite score for inclusion was not applied to allow 
symptomatic and asymptomatic individuals with COPD to participate.   
The MMSE, a widely administered cognitive screening tool, with a max score 
of 30, was administered to all participants. A score of 21 points or greater was 
required for inclusion in both the healthy and COPD groups. A score between 25 and 
30 was normal; the score of 21-24 suggested mild cognitive impairment. This 
inclusion level was determined based on the cognitive load necessary to complete 
the experimental tasks. Prospective participants completed the Reflux Symptom 
Index to determine the symptom severity of reflux. The RSI, a valid and reliable 
rating tool, contains 9 self-scored symptom statement items with ordinal ratings 
ranging 0 (no problem) to 5 (severe problem).  A score >13 is considered abnormal 
(Belafsky, Postma, & Koufman, 2002). Reflux may alter the sensory input response 
for swallowing. Healthy and COPD participants scored 15 for inclusion in this 
study. The higher cut-off score on the RSI for inclusion was set to avoid false 
positives of reflux symptoms in the COPD group. Specifically, RSI statements 
requiring COPD participants to rate symptoms of excess throat mucous, cough, or 









Prior to beginning the experimental swallow task, COPD and healthy 
participants completed three tasks for individual participant calibration to 
determine lung volume when swallowing. These tasks included: two 45 second tidal 
volume breathing segments, 5 swallow-like breathing trials, and 5 vital capacity 
maneuvers. The participant calibration tasks were completed using respiratory 
inductive plethysmography and concurrent spirometry.  A nose clip was secured on 
the nasal ala, preventing nasal airflow during these tasks. The participant completed 
the calibration and experimental tasks in an upright, seated position in a dental 
chair. Participants were instructed to “breathe naturally” for the tidal volume task. 
Swallow-like breathing instructions were to “imagine you are taking a drink of 
water per exhalation but do not swallow” (Hegland, Huber, Pitts, & Sapienza, 2009).  
Instructions for the vital capacity maneuver were to “take a deep breath and blow 
out hard as much as possible”.  
Participants swallowed 20 ml water boluses via medicinal cup across lung 
volume conditions for the experimental task.  Seven swallow trials at each lung 
volume condition were completed. Additional water bolus trials were completed if 
real-time signal analysis review verified a trial was not completed at the target lung 
volume or insufficient rest breaths occurred before or after the swallow.  All 
participants completed non-cued, natural swallow trials as the first experimental 
task condition to control for carry-over between tasks. The non-cued swallow 





provided a baseline recording of respiratory-swallow patterning. Three additional 
lung volume conditions were completed in a counterbalanced order across 
participants: (1) tidal volume (TV, volume at top of quiet inhalation), (2) total lung 
capacity (TLC, maximum volume after forced inhalation) and (3) resting expiratory 
level (REL, volume at end of quiet exhalation). Participants were instructed to 
achieve their target lung volume, insert the bolus into the mouth, and swallow. Each 
participant received instruction for the 3 cued lung volume conditions and 
demonstrated competence on each condition before beginning experiment task 
trials. Competence at lung volume conditions was determined by real-time signal 
analysis in LabChart (AD Instruments). Additional instruction on lung volume 
conditions was provided when participants were unable to reach a targeted lung 
volume condition.  Additional bolus trials were added to compensate for discarded 
trials. 
Participants rated their sensation of shortness of breath on the Modified 
Borg Dyspnea Scale before and after lung volume condition tasks using a visual 
scale. The Modified Borg Dyspnea Scale is a valid and reliable perceptual rating scale 
for disordered populations with COPD and asthma (Kendrick, Baxi, & Smith, 2000). 
Participants answered the question “How much difficulty is your breathing causing 
you now?” Ordinal scale responses ranged zero to ten with 0=nothing at all to 
10=maximal. Individuals responding in the 3 (moderate) to10 (maximal) scale 
range were provided a rest break and rescored. Participants responding with a 
score of <3 advanced to the next task. Two COPD participants reported changes on 





4 (somewhat severe).  All three participant’s dyspnea resolved within one minute to 
lower scores of <3 and each received a 3-5 minute break or rested until they 
indicated their verbal consent to continue.  Participant’s oxygenation levels were 
assessed during each event with a score >3 and found within the expected range. 
Participants completed baseline and interval blood oxygenation (SpO2%) 
screens using a clinical bedside pulse oximeter, the NellCor™ N-20 (Medtronic, 
Minneapolis, MN USA).  A finger-tip probe was placed on the index finger to 
determine the arterial oxygenation saturation percentage, the percent of red blood 
cells carrying oxygen. Values of 90-100% SpO2 are considered within acceptable 
range; healthy individuals are typically 94-100%. Participants with COPD can have 
resting oxygenation levels in the lower 90% range. Rest breaks after exertion 
typically return individuals back to their baseline oxygenation levels. One COPD 
participant experienced a singular instance of desaturation to <90% SpO2 but 
immediately returned to >90% when given a short 3-5 minute rest break. Dyspnea 
level rating via the Modified Borg Dyspnea Scale remained <3 participant response 
rating during the desaturation. 
A 10-point visual analogue scale for fatigue was administered at baseline and 
between lung volume condition tasks. A score of zero indicated energetic with no 
fatigue. A score of five specified moderate fatigue and a score of 10 was the worst 
possible fatigue. A score of three (mild-moderate fatigue) was the threshold to 





participants were provided a 3-5 minute rest break, reassessed, and able to proceed 
with tasks without incident. 
Off-Line Computation Methods 
Swallows that were not at the intended lung volume condition were excluded 
from analysis. Estimation of lung volume was calculated by taking an average of the 
end expiratory level (EEL) on a minimum of 3 tidal volume breaths preceding the 
experimental swallow trials. The RC and AB values at the time of BOT pressure 
increase onset, the marker of pharyngeal swallow onset in the study, were added to 
DataPad. A mean of end expiratory level (EEL) in quiet breaths before each swallow 
trial was computed and subtracted from each RC and AB value to account for signal 
drift.  The estimated lung volume (ELV) was calculated for each swallow trial using 
the formula: ELV= RC(x) + AB(1).  Mean vital capacity was determined from peak to 
trough difference in the spirometer signal from the participant’s vital capacity trials. 
The ELV was reported in liters while the percent vital capacity (%VC) was computed 
by (ELV/VC) *100. The expiratory reserve volume (ERV) was computed and 
included in the equation ELV=RC(x) +AB(1) +ERV. End expiratory levels in tidal 
breathing prior to each vital capacity (VC) trial were averaged.  The difference from 
EEL to vital capacity trough was determined using the spirometer signal.  
1.7  Results 
Power 
Pilot data (n=4) of pharyngeal swallowing durations were utilized to determine 





included 3 healthy participants and 1 COPD. Effect size computation was .27 using 
G*Power 3.1.9.2. An ANOVA repeated measures, within-between subject 
interactions were run with a Bonferroni correction to =0.017 to account for 3 
dependent variable measures. Power was set at .8 yielding a requisite sample size of 
26 total participants, 13 in each group (Figure 6a). 
Recruitment was slower than expected and the study only resulted in 10 healthy 
older adults (7 female, Mage=59.4) and 9 individuals with COPD (3 female, Mage=71.9) 
who completed the study.  If the effect size was higher, at 0.35, then the power 
would remain the same at 0.80 with 9 subjects in each group (Figure 6b).    
  
  
Figure 6a. Power analysis A. Output 
using G*Power 3.1.92. Total sample size 
is 26, with an effects size of 0.27 
Figure 6b Power analysis B. Output using 
G*Power 3.1.92. Total sample size is 18, with 







Statistical analyses were completed with IBM SPSS Statistics 24. 
Statistical analysis methods were determined by a statistical consultant. Participant 
group characteristics are provided in Table 6. 
Table 6 
 Characteristics of COPD and Healthy Participants 
 COPD (n=9)  Healthy (n=10) 
Criteria    
Age M=71.99 years 
Range=61-83 years 
 M=59.40years  
Range=50-77 years 




M=51.67% (SD=8.31)  M=82.2% (SD=7.4) 
FEV1 % Predicted M=52.33% (SD=16.95) 
Range= 34%-80% 











M=7.44 (SD=3.75)  M=2.50 (SD=2.37) 
Mini Mental State 
Examination 
(MMSE) 
M=27.89(SD=1.45)  M=29.70 (SD=0.48) 
Note. FEV1 % predicted is derived from the participant’s forced expiratory volume in one second 
divided by the average FEV1% in the population based on comparable age, gender, height, and 








Lung volume estimations  
A mixed model ANOVA analysis determined the effects of group (healthy or 
COPD) and within subject repeated lung volume conditions (NC, TV, TLC, and REL). 
The estimated lung volumes (in liters) during swallowing were significantly lower 
in individuals with COPD compared with older healthy, F(1,17)=8.119, p=.011 
(Table 7, Figure 7).  A statistically significant main effect was found of lung volume 
condition on estimated lung volume, F(3,51)=64.82, p=<.001 (Table 9). Pairwise 
comparisons of lung volume conditions demonstrated significant differences 
between all lung volume conditions (p<.001) except the NC and TV volume 
conditions, p=.249. Non-cued lung volume condition means, regardless of group, 
were lower than TV condition means (Table 7). The interaction between group and 



















Estimated Lung Volume and Percent Vital Capacity Means with Standard Deviations 
Condition COPD (n=9) Healthy (n=10) 
 Mean (SD) %VC(SD) Mean(SD)                               % VC(SD) 
NC 1.12(.55) 37.49(13.36) 1.98 (.87) 47.82(17.42) 
TV 1.38(.55) 47.74(11.39) 2.25(.83) 54.84(17.62) 
TLC 2.22(.95) 76.09(16.75) 3.24(.83) 80.15(16.98) 
REL .687(.41) 23.10(10.68) .1.30(.58) 32.17(13.89) 
Note. Mean is in liters. % Vital Capacity (%VC) is derived from estimated lung 
volume mean divided by vital capacity.  
 
Estimated lung volumes were also analyzed as a percent of vital capacity 
(%VC), calculated by ELV/VC*100. Mean vital capacity for individuals with COPD in 
this study was 2.81L (SD=.93) and healthy averaged 4.08L (SD=.921). Percent vital 
capacities for each group were similar across the 4 lung volume tasks (Table 7). 
Pharyngeal Durations 
The pharyngeal durations were very similar in the two groups (Table 8). Pharyngeal 
swallow durations were analyzed by mixed method ANOVA to determine group 
differences across volume conditions. Main effects for group (F(1,17)=.903, p=.355) 
and by ELV condition (F(3,51)=.311, p=.817) were not significant. An interaction 
between individuals with COPD and healthy across volume conditions was also not 
significant, F(3,51)=1.70, p=.178. Descriptive means suggest that the pharyngeal 
swallow durations in the NC condition tended to be longer in individuals with COPD 







Pharyngeal Swallow Durations 
Condition COPD (n=9) Healthy (n=10) 
NC .977(.31) .787(.20) 
REL .926(.23) .807(.26) 
TV .907(.25) .823(.24) 
TLC .841(.24) .841(.27) 
Note. Mean is in seconds. Parentheses values represent the standard deviations. 
 
Relationships Between Pharyngeal Durations and Estimated Lung Volume 
  The relationship between lung volume and pharyngeal swallow duration 
was analyzed by Pearson’s correlation analysis. In individuals with COPD, there was 
a significant inverse correlation between lung volume and the duration of the 
pharyngeal swallow, r(34)=-0.506, p=.002 (Figure 8). The estimated lung volume at 
the time of the swallow explained 26% of the variation in pharyngeal swallow 
duration.  In the older healthy participants, no relationships were found between 
estimated lung volume and pharyngeal swallow duration r(38)=.099, p=.542 (Figure 



















































Figure 8. Scatterplot of ELV and PD relationship in COPD participants 




Figure 9. Scatterplot of ELV and PD relationship in older healthy 






In individuals with COPD, correlation analyses within each lung volume 
condition were also computed.  In the normal swallows (NC) condition, there was a 
significant inverse relationship between ELV and pharyngeal swallow duration, 
r(1)=-0.817, p=.007 (Figure 10). Individuals with COPD also tended to have an 
inverse relationship with pharyngeal swallow duration in the TLC volume condition, 
r(1)=-0.606, p=.085. 
 
In the healthy adults, no relationship between ELV and PD was found within 





Figure 10. Scatterplot of ELV and PD relationship in NC swallow 







To compute the percent of respiratory cycles that resumed swallowing in the 
inspiratory phase, we combined the percent of cycles with an expiratory onset to an 
inspiratory swallowing offset with the percent of cycles that had  inspiratory onset 
to inspiratory off set. Box plots of the percentages in each group of swallowing 
offsets in the inspiratory cycle showed that the healthy participant group had some 











Within each lung volume condition, we conducted a t-test between groups 
with a directional hypothesis that the COPD participants would have a higher 
percentage of swallows resume on inspiration than the healthy participants. The 
Figure 11. Boxplots showing quartile distributions for percent of 






results are presented in Table 9. In the NC condition, the COPD participants had a 
greater percentage of swallows resuming on inspiration than the healthy 
participants, t(11)=-1.978, p=0.037.  
Table 9 
Percent of Swallow Resuming on Inspiration 
Condition COPD (S.D.) Healthy (S.D.) T- test (p value) 
REL 54.71 (30.7)  32.43 (32.15)  -1.54 (0.071) 
NC 31.35 (28.87) 10.54 (13.46)  -1.978 (0.037) 
TV 18.851 (32.31)  10.00 (31.623) -0.602 (0.278) 
    
 
A one-way repeated measures ANOVA was conducted to determine whether 
individuals with COPD had statistically significant differences in resumption of 
respiration in inspiration across lung volume conditions. Analyses revealed that 
lung volume condition at the time of the swallow results in significant changes in 
percent of swallows resumed in inspiration (F(3,24)=7.803, p=.001, partial 
2=.494.).  The percent occurrence for COPD participants resuming respiration on 
inspiration after the swallow decreased as lung volumes increased (Figure 11). Post 
hoc analysis with a Bonferroni adjustment revealed that the percent of respiration 
resumption in inspiration was statistically significantly decreased in TLC compared 
with REL (43.59(95% CI, 14.82 to 72.36) %, p=.005) and in TV compared with REL 
(35.85(95% CI, 14.37 to 57.34) %, p=.002. Other post hoc comparison groups 
including NC swallows with cued swallow lung volume conditions were not 







Lung volume at the time of the swallow has been posited to play an 
important role in the coordination of breathing and swallowing by altering sensory 
feedback from respiration.  Pulmonary stretch receptors provide sensory input to 
the central pattern generators for respiration which may assist in regulation of the 
requisite, coordinated patterning between swallowing and respiration.  The pattern 
ensures the cessation of respiration during the swallow followed by a resetting in 
the preferred expiration phase (Martin-Harris et al., 2003; Martin-Harris, 2008; 
Shaker, 1992). This study investigated the effects of lung volume on swallow timing 
and respiration resetting patterning in individuals with COPD, in comparison with 
healthy participants. 
Lung Volume for Swallowing 
Based on the study findings, individuals with COPD swallow had significantly 
lower lung volumes than their older, healthy peers. Given the COPD disease 
characteristics of bronchoconstriction, decreased airflow within the smaller 
airways, and thoracic muscle wasting with disease progression (Gatta, Fredi, 
Aliprandi, Pini, & Tantucci, 2013), swallowing at a lower lung volume was expected.  
Despite the significantly lower lung volume in COPD compared with healthy 
individuals, the COPD had similar percent vital capacity values to the healthy 
participants. The  similarity suggest that both groups used similar proportions of 





reduced in their vital capacity compared with the healthy participants, similar to a 
previous study (Yuan et al., 2014).  
Wheeler-Hegland et al. (2009) posited that there is a lung volume range that 
evokes a safe and effective swallow. They found that young healthy swallow at 
respiratory volumes between 43% and 64% of their vital capacity. The current 
study found that natural, non-cued swallows in older healthy participants and 
individuals with COPD swallow occurred at 47.82% and 37.49% of vital capacity, 
respectively. The swallows of our older healthy participants were consistent with 
the range of normal swallows of between 43%-64% VC of Wheeler-Hegland et al. 
(2009), even though our healthy participants (aged 50 to 83) were older than those 
of Wheeler-Hegland et al. (2009) (aged 19-28). This age difference may account for 
the lower %VC findings in this study. Aging is associated with decreases in vital 
capacity due to changes in musculoskeletal function (Lalley, 2013). This raises the 
question whether the target %VC for a safe, effective swallow changes with age, 
which should be explored further. 
On the other hand, individuals with COPD tended to swallow at a slightly 
lower %VC than their older healthy peers and potentially may have been further 
away from the ideal target %VC.  Hyperinflation of the lungs occurs with 
progressive severity of COPD and may have played a role in the lower estimated 
lung volumes found in the COPD participants this study. Air volume residuals in the 
lungs after forceful exhalation in a vital capacity maneuver were not measured in 





volume capacity for performing everyday tasks, such as swallowing. The lower 
estimated lung volume in swallowing may further support the hypothesis that 
persons with COPD may not adequately activate pulmonary stretch receptors or 
subglottal pressure receptors for adequate feedback to the respiratory central 
pattern generator for coordinating respiration with swallowing.  
Swallow Timing and Lung Volume  
Lung volume plays a significant role in altering the central neural control 
coordination between respiration and swallowing. However, subglottal pressure is 
increased when the vocal folds adduct during a swallow. The amount of increase in 
subglottal pressure is driven by lung volume paired with expiratory recoil forces 
(Gross, Carrau, Slivka, Gasser, Smith,..Sciurba, 2012).  Although we did not measure 
subglottal pressure in this study, it may have been reduced by reduced changes in 
volume for swallowing in the COPD subjects.  Afferent pulmonary stretch receptors 
may also have inputs to the central pattern generator for swallowing control to 
modulate the swallow motor sequence (Jean, 2001).  Possibly, a reduction in 
subglottal pressure change due to reduced change in pulmonary volume may have 
played a role in the pathophysiology of swallowing control in the COPD participants 
in this study and should be explored further. Swallowing at a low volume near 
residuals in healthy participants yielded a significantly slower swallow pattern than 
swallowing at the top of inspiratory reserve volume (Gross et al., 2003).  
Cassiani et al., (2015) found pharyngeal swallow durations of COPD patients 





swallow has been posited as a compensatory mechanism to allow longer time 
periods for bolus movement through the pharynx (Mokhlesi et al., 2002; Chaves et 
al., 2014).  We did not find increased pharyngeal durations in COPD in this study, 
however, we did find a strong inverse relationship between pharyngeal duration 
and estimated lung volume in individuals with COPD. The COPD participants had 
longer pharyngeal durations at lower lung volumes. This relationship was strongest 
in the non-cued swallowing condition in the COPD participants when they had 
pharyngeal durations of .98s and were using 1.12L or 37.49% VC, which is below 
the requisite volume for swallowing established in previous research. Others have 
found longer swallow durations result in increased respiratory rates in individuals 
with COPD (Shaker et al., 1992).  It is unclear whether the prolonged pharyngeal 
durations at low lung volumes for swallowing in the COPD participants were the 
result of either a compensatory strategy developed by the patients when at low lung 
volumes or a reflexive response to increase respiratory rate due to air hunger.  If it 
were a reflexive response then prolonged pharyngeal durations would result in an 
increase in respiratory rate, which was not evaluated here. However, the increased 
incidence of resuming respiration on inspiration after a swallow in the COPD 
participants in the low volume conditions suggest that increased respiratory rate 
due to air hunger may have played a role. 
Respiratory-Swallow Patterning 
This study also examined the respiratory-swallow patterning across lung 





swallow in an expiratory-swallow-expiratory pattern (Cedborg et al., 2010; Martin-
Harris et al., 2005; Martin-Harris et al., 2003; Shaker et al., 1992; Wheeler Hegland, 
et al., 2009). Alterations in the respiratory-swallow pattern can result in increased 
risk of aspiration. Multiple studies determined that COPD respiratory-swallow 
patterning deviates from the preferred initiation and resumption of respiration in 
expiration (Cedborg et al., 2010; Martin-Harris et al., 2005; Martin-Harris et al., 
2003; Shaker et al., 1992; Wheeler Hegland et al., 2009).  Similar to previous studies, 
individuals with COPD in this study tended to resume respiration in inspiration 
more than their older healthy peers.  Importantly, COPD restarted respiration after a 
swallow less often in inspiration at the higher lung volumes, TLC and TV. COPD 
participants swallowing at REL were significantly more likely to resume respiration 
on inhalation than when they were swallowing in the TLC or TV.  
Summary 
 The study provided new evidence that individuals with COPD swallow at 
lower lung volumes than their healthy, older peers.  Further, individuals with COPD 
demonstrated an inverse relationship between pharyngeal swallow duration and 
the lung volume at the time of the swallow which was not evidenced in the older 
healthy participants. Pharyngeal swallow duration was longer at the lower lung 
volumes in individuals with COPD. This relationship should be investigated further 
to determine whether longer or shorter pharyngeal swallow duration impacts the 





 This study found that individuals with COPD resume respiration in 
inspiration significantly more often in their natural swallowing in the non-cued 
condition, placing them potentially at greater risk for aspiration, compared with 
their older healthy peers.  This finding supports previous studies (Cedborg et al., 
2010; Martin-Harris et al., 2005; Martin-Harris et al., 2003; Shaker et al., 1992; Wheeler 
Hegland, et al., 2009). Importantly, we determined that increasing lung volume at the 
time of the swallow can alter the respiratory-swallow pattern into resumption of 
breathing in exhalation at the time of the swallow in individuals with COPD. Future 
research would be beneficial in determining if swallowing at a higher lung volume 
also reduces incidence of aspiration and could be used as an intervention in patients 
with COPD.  
Future studies with a focus on improving respiratory function such as airflow 
exchange and recoil forces should determine if altering respiratory function results 
in improved swallowing outcomes, reduces incidents of COPD exacerbations, and 
improves quality of life for individuals with COPD. Studies should examine whether 
respiratory muscle strength training can improve swallowing in COPD. Resistive 
respiratory training exercises, such as Inspiratory Muscle Strength Training (IMST), 
improve inspiratory muscle strength in individuals with COPD (Geddes et al., 2008; 
Geddes et al., 2005) and could increase inspiratory volume prior to the swallow. 
Expiratory Muscle Strength Training (EMST) improves hyolaryngeal timing and 
movement for swallowing in patients with Parkinson Disease (Troche et al., 2010).  
EMST also improves expiratory force for a productive cough through active 





& Sapienza, 2014).  The effects of IMST and EMST in individuals with COPD to 
improve lung volume at the time of the swallow may offer benefits for improving 









Small sample size limits ability to generalize the findings and may have 
impacted the statistical analyses. In the pilot testing, we found that the effect size 
was 0.27, and the power analysis indicated that 26 participants would be needed in 
each group. We were only able to recruit 10 in the healthy group and 9 in the COPD 
group.  The effect sizes that the results yielded, however, were higher in this study. 
For estimated lung volume, the mean of the Cohen’s d effect sizes across the four 
lung volume conditions based on the data in Table 7, averaged 1.07, while the mean 
Cohen’s d effect sizes for the 3 conditions in percent swallows finishing on 
inspiration in Table 9 averaged 0.83. Thus, both were strong effect sizes much 
higher than the pilot testing results.  The power of the study based on these effect 
sizes was ≥0.99.  
Recruitment of participants in this study exceeded one year and may be 
attributed to conducting the study in a rural hospital.  The limited sampling pool 
impacted abilities to effectively stratify participants for the study. This resulted in 
gender inequality between groups. The COPD group gender composition of men 
(n=6) compared with women (n=3) may be skewed based on recent trends of more 
women than men being diagnosed (American Lung Association, 2013). Additional 
participant sampling should be completed to address the sample inequalities. 
COPD participant exclusion criteria excluded individuals with the most 





in the study.  Study participants were predominately in the moderate (n=3) to 
severe (n=5) COPD severity stage. This study did not include equal representation 
from the mild severity (n=1) nor the most severe. Importantly, the most severe 
COPD are the individuals most commonly referred for swallowing assessment. 
Disease progression and increased frequency of exacerbations is related to 
increased aspiration risk (Terada, 2011).  Conversely, mild COPD and the emergence 
of dysphagia symptoms is less understood.  Additional larger studies need to be 
completed to include the range of COPD severity in sampling to elucidate the 
emergence and progression of dysphagia in individuals with COPD.  
 COPD participants were included in the study regardless of reported 
symptoms of swallowing impairment to ensure inclusion of subclinical dysphagia in 
COPD participants. Three participants scored outside the normal range on the DHI. 
Only one of the participants who scored a moderate severity on the DHI, was 
diagnosed with dysphagia. Two other COPD participants scored in the mild severity 
range on the DHI. The remaining 6 COPD participants reported no handicapping 
effects on their swallowing.  
This study did not include videofluoroscopic assessment of swallowing to 
correlate the timing and volume measures with swallow physiology. Future studies 
should include a greater spread of individuals with COPD expressing self-perceived 
swallow symptoms and inclusion of videofluoroscopy. In clinical practice, 
individuals with COPD often underreport symptoms of dysphagia that are later 





from COPD attributing their swallowing symptoms, such as cough, throat clearing, 
or increased secretions, to their respiratory disorder.  
This study examined individuals in the stable state of the disease process. 
Exacerbations of COPD result in reduced pulmonary function and increased risk of 
aspiration. Abnormal swallowing examination results occur in increased 
frequencies during COPD exacerbations as there is a strong relationship between 
swallowing dysfunction and exacerbations in COPD (Terada et al., 2010). 
Exacerbation symptoms such as increased phlegm production, significant shortness 
of breath, and increased respiratory drive are posited to result in increased 
discoordination between respiration and swallowing. However, research has largely 
examined individuals with COPD in the stable state. Future research should focus on 
determining effects of exacerbated state on swallow function and safety in 














Lung volumes in individuals with COPD were reduced during the swallow and may 
contribute to other swallow physiology dysfunction. Individuals with COPD 
demonstrate higher pharyngeal swallow durations when swallowing at lower lung 
volumes. This relationship between estimated lung volume and pharyngeal swallow 
duration was not present in the older healthy. COPD individuals were found to 
resume respiration in inspiration post-swallow significantly more often than 
healthy. Further, increasing lung volume at the time of the swallow in individuals 
with COPD resulted in a significant reduction of respiration resumption in the 
inspiratory phase post-swallow. Resuming respiration in the expiratory phase may 
decrease risk of aspiration.  Additional research investigating lung volume effects on 
swallow physiology and functional outcomes is needed to develop efficacious 
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